6-month data of the LEVANT 2 trial presented at TCT 2013

(Cardiovascular Research Foundation) The first clinical trial in the United States to study the use of drug coated balloons for femoropopliteal artery disease found the procedure is promising for safety and efficacy at six months. Six month data of the LEVANT 2 trial was presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interve...